Erlotinib intermediates manufacturer
| Name | N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
| CAS | 262368-30-9 |
| Purity | 99.5% |
| Appearance | white powder |
| Molecular formula | C14H22N4O |
| Molecular weight | 262 |
| EINECS number | 919-251-0 |
Intedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
Treatment of systemic sclerosis.
Treatment of idiopathic pulmonary fibrosis.
Argatef is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.
